130 related articles for article (PubMed ID: 36593152)
1. "Positive Kidney Health": Implementation and design of a pharmacist-led intervention for patients at risk for development or progression of chronic kidney disease.
Vu A; Nicholas SB; Waterman AD; Madievsky R; Cheng F; Chon J; Fu JY; Mangione CM; Norris KC; Duru OK
J Am Pharm Assoc (2003); 2023; 63(2):681-689. PubMed ID: 36593152
[TBL] [Abstract][Full Text] [Related]
2. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
[TBL] [Abstract][Full Text] [Related]
3. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.
Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; El-Dahiyat F
Sci Rep; 2024 Mar; 14(1):7284. PubMed ID: 38538618
[TBL] [Abstract][Full Text] [Related]
5. Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.
Vassalotti JA; Centor R; Turner BJ; Greer RC; Choi M; Sequist TD;
Am J Med; 2016 Feb; 129(2):153-162.e7. PubMed ID: 26391748
[TBL] [Abstract][Full Text] [Related]
6. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: A nationwide retrospective cohort study.
Kaewput W; Thongprayoon C; Chewcharat A; Rangsin R; Satirapoj B; Kaewput C; Suwannahitatorn P; Bathini T; Mao MA; Cato LD; Harrison AM; Vaitla P; Cheungpasitporn W
Ther Apher Dial; 2020 Dec; 24(6):677-687. PubMed ID: 31997551
[TBL] [Abstract][Full Text] [Related]
7. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
[TBL] [Abstract][Full Text] [Related]
8. Annual deterioration of renal function in hypertensive patients with and without diabetes.
Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
[TBL] [Abstract][Full Text] [Related]
9. Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics.
Alicic RZ; Short RA; Corbett CL; Neumiller JJ; Gates BJ; Daratha KB; Barbosa-Leiker C; McPherson S; Chaytor NS; Dieter BP; Setter SM; Tuttle KR
Am J Nephrol; 2016; 44(2):122-9. PubMed ID: 27487357
[TBL] [Abstract][Full Text] [Related]
10. A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report.
Walker RC; Marshall MR; Polaschek NR
BMC Fam Pract; 2014 Sep; 15():155. PubMed ID: 25239726
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
[TBL] [Abstract][Full Text] [Related]
12. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
13. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
14. Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.
Papastergiou J; Donnelly M; Li W; Sindelar RD; van den Bemt B
Can J Kidney Health Dis; 2020; 7():2054358120922617. PubMed ID: 32523707
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
[TBL] [Abstract][Full Text] [Related]
16. Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics.
Bansal S; Mader M; Pugh JA
Kidney360; 2020 Sep; 1(9):904-915. PubMed ID: 35369564
[TBL] [Abstract][Full Text] [Related]
17. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans.
Peralta CA; Frigaard M; Rubinsky AD; Rolon L; Lo L; Voora S; Seal K; Tuot D; Chao S; Lui K; Chiao P; Powe N; Shlipak M
BMC Nephrol; 2017 Apr; 18(1):132. PubMed ID: 28399844
[TBL] [Abstract][Full Text] [Related]
19. Pharmacist impact on medication dosing and billable coding accuracy in outpatients with chronic kidney disease.
Cypes IN; Prohaska ES; Melton BL
J Am Pharm Assoc (2003); 2021; 61(2):e153-e158. PubMed ID: 33160871
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
